Key Insights

Highlights

Treatment Research

2 treatments under study, led by Sample Of Blood Or Saliva

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02099734Recruiting

Germ Cell Tumor and Testicular Tumor DNA Registry

Showing all 1 trials

Research Network

Common Treatments

  • Sample Of Blood Or Saliva1
  • Questionnaires1

Active Sponsors

  • Memorial Sloan Kettering Cancer Center1

Top Investigators

Related Conditions

  • Germ Cell Tumor1

Activity Timeline